Public To Sign Beam At Statehouse For New James Cancer Hospital, Critical Care Center

May 15, 2012

COLUMBUS, Ohio – The final steel beams of the new James Cancer Hospital and Solove Research Institute and Critical Care Center will be raised on May 21 – an important milestone in building the future of medicine in central Ohio.

The beams – which are part of the $1.1 billion expansion project at The Ohio State University Wexner Medical Center – are traveling around Columbus, and will be available for the public to sign at:

  • May 16: 11 a.m. – 1:30 p.m., Ohio Statehouse plaza facing High Street
  • May 17: noon – 6 p.m., Stefanie Spielman Comprehensive Breast Center, 1145 Olentangy River Road

Media are invited to cover the May 16 event at the Statehouse, where Dr. David Schuller, vice president of Wexner Medical Center Expansion and Outreach, will be available to discuss the project from 11:30 a.m. to 12:30 p.m.

To "virtually" sign the beam – which allows faculty, staff, students and the community the opportunity to leave a personal stamp on the expansion – go to Facebook.com/OSUMedicalCenter or follow @OSUWexMed on Twitter. For more information call 800-293-5123.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 210-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top 20 cancer hospitals in the nation as ranked by U.S. News & World Report.

# # #

Contact: Eileen Scahill, Medical Center Public Affairs and Media Relations, 614-293-3737, or Eileen.Scahill@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations

614-685-5420 (direct)

614-293-3737 (main)

Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

Nobel Prize Winner Carol Greider to Present Annual Block Lecture at Ohio State

Carol Greider, PhD, recipient of the 2009 Nobel Prize in Physiology or Medicine, will receive the 21st annual Herbert and Maxine Block Memorial Lectureship Award for Achievement in Cancer. The Block...

Read More

Researchers Detail Reasons for Ibrutinib Therapy Discontinuation in Chronic Lymphocytic Leukemia

About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical...

Read More

Exciting Research in Lung Cancer Diagnosis and Treatments

This week on Toward a Cancer-Free World, we see how lung cancer treatments are now changing, thanks to exciting new research at The James.

Read More